XML 38 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Revenues:        
Revenue from collaborative research $ 14,681 $ 18,283 $ 91,444 $ 41,886
Grant revenue 0 99 1,232 435
Total revenues 14,681 18,382 92,676 42,321
Costs and expenses:        
Research and development 24,103 18,632 68,227 50,536
General and administrative 6,021 3,678 16,050 11,081
Total costs and expenses 30,124 22,310 84,277 61,617
Income (loss) from operations (15,443) (3,928) 8,399 (19,296)
Other income (expense) 1 0 (88) 1
Net comprehensive income (loss) $ (15,442) $ (3,928) $ 8,311 $ (19,295)
Basic net income (loss) per common share (in dollars per share) $ (0.46) $ (0.14) $ 0.27 $ (0.71)
Diluted net income (loss) per common share (in dollars per share) $ (0.46) $ (0.14) $ 0.25 $ (0.71)
Weighted average shares outstanding, basic (in shares) 33,339,163 27,751,437 30,952,458 27,227,151
Diluted weighted average common shares outstanding (in shares) 33,339,163 27,751,437 32,960,233 27,227,151